Enhanced Recovery After Surgery Exercise Improve Perioperative Frailty
NCT ID: NCT04964856
Last Updated: 2021-07-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
98 participants
INTERVENTIONAL
2021-05-01
2022-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Objective to evaluate the efficacy of ERAS exercise improve perioperative frailty in patients undergoing elective laparoscopic colorectal surgery
Participants: Patients undergoing elective laparoscopic colorectal surgery over 18 years old.
The research intervention was ERAS exercise
The study design was a randomized, parallel controlled trial
ERAS exercise in perioperative period as the experimental group. No ERAS exercise group was the control group.
The sample size was estimated according to the main efficacy index ( the attenuation of frailty after 7 days surgery) of this study. It was assumed that the attenuation of frailty in the ERAS exercise group was better than that of the control group. The parameters were set as test level (alpha) of 0.050 using a two-sided two-sample unequal-variance t-test, β = 0.9, according to the results of previous clinical trials and combined with literature, the population mean difference was 0.6 with standard deviations of 0.8 for the experimental group and 0.8 for the control group. the experimental group: the control group was 1:1, 39 cases in each group, considering the 20% shedding rate, 49 cases in the experimental group and 49 cases in the control group were selected.
1. The experimental group The patients take ERAS exercise from hospitalization to 30 days after operation.
2. The control group The patients do not take ERAS exercise in perioperative period.
Efficacy evaluation
1. The primary endpoint of the study was the attenuation of frailty via Frailty Phenotype (FP) between before surgery and 7days, 30 days after surgery.
2. Secondary endpoints included the 6-minute walk test (6MWT),nutritional risk screening (NRS2002), anxious and depressive states, activities of daily living (ADL),postoperative complications and mortality,short-term recovery quality,postoperative pain.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prehabilitation - Enhanced Recovery After Colorectal Surgery
NCT02746731
The Protocol of Enhanced Recovery After Surgery in Colorectal Surgery
NCT00498290
Effects of Rocking on Postoperative Ileus Duration Study
NCT00494806
ERAS Protocol on the Incidence of Postoperative Complications Following Intestinal Surgery
NCT02728973
Effect of Preoperative Abdominal Effleurage on Postoperative Constipation
NCT07344532
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ERAS exercise in perioperative period.
The patients take ERAS exercise from hospitalization to 30 days after operation.
ERAS exercise
Take ERAS exercise twice a day from hospitalization to 30 days after surgery
No ERAS exercise in perioperative period.
The patients do not take ERAS exercise in perioperative period.
No ERAS exercise
Don't take ERAS exercise in perioperative period
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ERAS exercise
Take ERAS exercise twice a day from hospitalization to 30 days after surgery
No ERAS exercise
Don't take ERAS exercise in perioperative period
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18≤age≤100 years old, no gender limit;
* The ASA score is between I and Ⅲ;
* Clearly understand and voluntarily participate in the study, and sign an informed consent form.
Exclusion Criteria
* Those with a history of cognitive dysfunction;
* Those with a history of neuromuscular diseases,;
* American Society of Anesthesiologists class ⩾IV;
* Those with a history of spontaneous pneumothorax, coagulation dysfunction,
* Acute and systemic infectious diseases, moderate or higher fever;
* Pregnant women;
* History of drug abuse;
* Those who judged by the physician in charge to be unsuitable for ERAS-exercise;
* Other severe cardio-pulmonary diseases that would affect the 6MWD
* Those failure to obtain informed consent.
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
First Affiliated Hospital of Chongqing Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Min Su
Director of Department of Anesthesiology, The First Affiliated Hospital of Chongqing Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
the First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Yang F, Yuan Y, Liu W, Tang C, He F, Chen D, Xiong J, Huang G, Qian K. Effect of prehabilitation exercises on postoperative frailty in patients undergoing laparoscopic colorectal cancer surgery. Front Oncol. 2024 Sep 12;14:1411353. doi: 10.3389/fonc.2024.1411353. eCollection 2024.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CYYYMZK-E
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.